vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $28.5M, roughly 1.1× Creative Media & Community Trust Corp). RxSight, Inc. runs the higher net margin — -28.1% vs -125.8%, a 97.7% gap on every dollar of revenue. On growth, Creative Media & Community Trust Corp posted the faster year-over-year revenue change (3.6% vs -18.9%). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -8.5%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CMCT vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.1× larger
RXST
$32.6M
$28.5M
CMCT
Growing faster (revenue YoY)
CMCT
CMCT
+22.5% gap
CMCT
3.6%
-18.9%
RXST
Higher net margin
RXST
RXST
97.7% more per $
RXST
-28.1%
-125.8%
CMCT
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-8.5%
CMCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
RXST
RXST
Revenue
$28.5M
$32.6M
Net Profit
$-11.4M
$-9.2M
Gross Margin
77.5%
Operating Margin
-125.6%
-34.8%
Net Margin
-125.8%
-28.1%
Revenue YoY
3.6%
-18.9%
Net Profit YoY
-11.4%
-54.1%
EPS (diluted)
$-3.89
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
RXST
RXST
Q4 25
$28.5M
$32.6M
Q3 25
$26.2M
$30.3M
Q2 25
$29.7M
$33.6M
Q1 25
$32.3M
$37.9M
Q4 24
$27.5M
$40.2M
Q3 24
$28.6M
$35.3M
Q2 24
$34.4M
$34.9M
Q1 24
$34.0M
$29.5M
Net Profit
CMCT
CMCT
RXST
RXST
Q4 25
$-11.4M
$-9.2M
Q3 25
$-12.5M
$-9.8M
Q2 25
$-9.0M
$-11.8M
Q1 25
$-6.1M
$-8.2M
Q4 24
$-10.3M
$-5.9M
Q3 24
$-10.4M
$-6.3M
Q2 24
$-796.0K
$-6.1M
Q1 24
$-3.7M
$-9.1M
Gross Margin
CMCT
CMCT
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
CMCT
CMCT
RXST
RXST
Q4 25
-125.6%
-34.8%
Q3 25
-47.7%
-40.1%
Q2 25
-30.3%
-41.6%
Q1 25
-19.0%
-28.2%
Q4 24
-128.8%
-21.5%
Q3 24
-36.9%
-26.1%
Q2 24
-1.6%
-23.9%
Q1 24
-10.7%
-36.2%
Net Margin
CMCT
CMCT
RXST
RXST
Q4 25
-125.8%
-28.1%
Q3 25
-47.5%
-32.4%
Q2 25
-30.3%
-35.0%
Q1 25
-18.9%
-21.6%
Q4 24
-129.8%
-14.8%
Q3 24
-36.3%
-17.9%
Q2 24
-2.3%
-17.4%
Q1 24
-11.0%
-30.8%
EPS (diluted)
CMCT
CMCT
RXST
RXST
Q4 25
$-3.89
$-0.22
Q3 25
$-23.52
$-0.24
Q2 25
$-18.94
$-0.29
Q1 25
$-20.73
$-0.20
Q4 24
$97.71
$-0.14
Q3 24
$-305.04
$-0.16
Q2 24
$-98.64
$-0.16
Q1 24
$-125.46
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$15.4M
$228.1M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
$275.7M
Total Assets
$859.2M
$311.8M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
RXST
RXST
Q4 25
$15.4M
$228.1M
Q3 25
$17.3M
$227.5M
Q2 25
$27.8M
$227.5M
Q1 25
$19.8M
$229.3M
Q4 24
$20.3M
$237.2M
Q3 24
$18.5M
$237.1M
Q2 24
$29.3M
$233.3M
Q1 24
$21.3M
$125.4M
Total Debt
CMCT
CMCT
RXST
RXST
Q4 25
$509.8M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
Q3 24
$478.3M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
RXST
RXST
Q4 25
$265.4M
$275.7M
Q3 25
$281.9M
$276.0M
Q2 25
$287.1M
$278.0M
Q1 25
$293.0M
$279.3M
Q4 24
$304.5M
$281.2M
Q3 24
$321.0M
$277.3M
Q2 24
$351.1M
$275.2M
Q1 24
$369.9M
$163.9M
Total Assets
CMCT
CMCT
RXST
RXST
Q4 25
$859.2M
$311.8M
Q3 25
$871.8M
$308.5M
Q2 25
$885.0M
$309.0M
Q1 25
$882.3M
$313.0M
Q4 24
$889.6M
$318.6M
Q3 24
$868.0M
$310.5M
Q2 24
$891.2M
$305.5M
Q1 24
$887.5M
$183.2M
Debt / Equity
CMCT
CMCT
RXST
RXST
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
RXST
RXST
Operating Cash FlowLast quarter
$5.8M
$-1.1M
Free Cash FlowOCF − Capex
$-2.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
RXST
RXST
Q4 25
$5.8M
$-1.1M
Q3 25
$3.7M
$-1.2M
Q2 25
$-2.5M
$-4.4M
Q1 25
$1.2M
$-8.8M
Q4 24
$17.0M
$-4.3M
Q3 24
$10.3M
$650.0K
Q2 24
$3.9M
$-4.0M
Q1 24
$1.6M
$-9.3M
Free Cash Flow
CMCT
CMCT
RXST
RXST
Q4 25
$-2.3M
Q3 25
$-1.8M
Q2 25
$-5.9M
Q1 25
$-9.4M
Q4 24
$-5.1M
Q3 24
$-453.0K
Q2 24
$-5.5M
Q1 24
$-11.3M
FCF Margin
CMCT
CMCT
RXST
RXST
Q4 25
-6.9%
Q3 25
-5.8%
Q2 25
-17.6%
Q1 25
-24.8%
Q4 24
-12.7%
Q3 24
-1.3%
Q2 24
-15.9%
Q1 24
-38.2%
Capex Intensity
CMCT
CMCT
RXST
RXST
Q4 25
3.5%
Q3 25
1.9%
Q2 25
4.6%
Q1 25
1.5%
Q4 24
2.1%
Q3 24
3.1%
Q2 24
4.4%
Q1 24
6.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMCT
CMCT

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons